N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.
D000116:Acetylgalactosamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000276:immunology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D005260:Female; D005688:Galactosamine / Q000031:analogs & derivatives*; D005944:Glucosamine / Q000031:analogs & derivatives*; D007109:Immunity / Q000187:drug effects*; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; C021154:N-bromoacetyl-beta-D-glucosamine tetra-O-acetate; C021153:N-bromoacetyl-beta-D-galactosamine tetra-O-acetate; D005688:Galactosamine; D000116:Acetylgalactosamine; D005944:Glucosamine; D000117:Acetylglucosamine